AstraZeneca announced two deals in two parts of the business it is targeting for growth, underlining the pace of activity at the drugmaker as it pursues a target of nearly doubling sales by 2023.
from WSJ.com: US Business http://ift.tt/1Qpz4pO
via IFTTT
No comments:
Post a Comment